Altered IL-1β signaling has also been demonstrated to occur in common neurodegenerative diseases such as Alzheimer's disease (Alam et al., 2016), in which neurogenic changes have also been reported (Winner and Winkler, 2015). The gene discussed is IL1B; the disease is neurodegenerative disease.